Shows / AVBCC Value-Based Voices

AVBCC Value-Based Voices
The Association for Value-Based Cancer Care’s (AVBCC) podcast series addresses the ever-evolving
landscape of value related to cancer care in the United States. Our goal is to foster informed dialogue, promote transparency, and empower all players to navigate the rapidly changing landscape of cancer care with clarity and confidence.
Episodes
AVBCC Value-Based VoicesTed Slafsky on 340B's Triple Threat: CMS Cuts, the Rebate Model Fight & Contract Pharmacy in Court
CMS has just finalized a cut to hospital payments for 340B drugs, from ASP+6% down to ASP-28%. The lawsuits are already on the way. Host Jayson Slotnik sits…
AVBCC Value-Based VoicesMedicare Advantage, AI, MFN, China, and Consensus Building: Powerful Insights from HLC
Value-Based Voices welcomes Maria Ghazal, JD, MA, President & CEO, Healthcare Leadership Council, for a dynamic conversation spanning Medicare Advantage, prior…
AVBCC Value-Based VoicesWho Gets Access? Understanding the New Reality of Cancer Drug Coverage
Are oncology treatments losing their "special status" with payers? In this episode of Value-Based Voices, host Brian Reid, MS, Principal of Reid Strategic and…
AVBCC Value-Based VoicesAI at the Point of Care: Inside OpenEvidence's Approach to Smarter Clinical Decisions
Artificial intelligence is rapidly reshaping healthcare, but what does that look like in the day-to-day practice of oncology? In this episode of AVBCC's…
AVBCC Value-Based VoicesFrom Patient to Person: Redefining Cancer Care at the AVBCC LA Regional Collaborative
In this episode of Value‑Based Voices, host Deirdre “Dee” Saulet, PhD, Chief Strategy Officer, Jasper Health, and AVBCC Southwest Regional Collaborative…
AVBCC Value-Based VoicesRed Tape: Real Consequences for Patients with Cancer
What happens when patients with cancer spend weeks navigating insurance requirements before receiving physician-prescribed care? In our latest episode of…
AVBCC Value-Based VoicesPart D Upheaval: Why the Cancer Community Needs to Pay Attention
In this episode of Value-Based Voices, host Jayson Slotnik, JD, MPH, Partner at Health Policy Strategies, and AVBCC Board Member, sits down with Joel White…
AVBCC Value-Based VoicesCan the U.S. Keep Its Edge? FDA Policy, China’s Momentum, and the Future of Innovation
In this follow up conversation, Jayson Slotnik, JD, MPH, Partner at Health Policy Strategies and AVBCC Board Members, and Steve Usdin, Senior Editor…
AVBCC Value-Based VoicesThe Future of the FDA: What Comes Next?
In this first of a 2-part series featuring Steve Usdin, Senior Editor, Washington, BioCentury Publications, host Jayson Slotnik, JD, MPH, Partner at Health…
AVBCC Value-Based VoicesReflections on the NCCN
In this episode of Value-Based Voices, we delve into the mission and inner workings of the NCCN, a cornerstone organization shaping cancer treatment standards…
AVBCC Value-Based VoicesAdvancing Cancer Research and Innovation through Collaboration at GCRIS 2026
We're taking a deep dive into the upcoming Global Cancer Research and Innovation Symposium (GCRIS) in this latest episode of Value-Based Voices. Join GCRIS…
AVBCC Value-Based VoicesBreaking the Model: Can Value-Based Insurance Deliver?
Most cancer drugs today are more effective and accessible than ever—yet patients often face crushing costs because our healthcare system still values profit…
AVBCC Value-Based VoicesFrom the Human Genome Project to 48 Hours: The Rapid Evolution of Tumor Biology
Most treatments and diagnostics once took years and hundreds of millions of dollars. Today, it costs less than $100,000 to sequence a genome and open the door…
AVBCC Value-Based VoicesNavigating Value and Policy in U.S. Cancer Care and Pharma Pricing
International reference pricing could drastically reshape drug costs in the U.S. and threaten domestic innovation. In this latest episode of AVBCC’s…
AVBCC Value-Based VoicesMost Favored Nation and What's Next
Most companies, and even policymakers, are betting big on importing international drug prices — but what does that really mean for cancer care in America? In…
AVBCC Value-Based VoicesAI Revolution: Breaking Pharmacy Chains with Harry Travis, BS Pharm, MBA, and Ira Klein, MD, MBA, FACP
There are countless opportunities hidden in the data-driven tasks pharmacists do every day, and AI is ready to unlock them. But what happens when automation…
AVBCC Value-Based VoicesConsolidation Versus Independence in Cancer Care
Is consolidation in cancer care truly the best path forward, or does independence offer greater benefits? In this episode of Value-Based Voices Sarah Alwardt…
AVBCC Value-Based VoicesInsights from JP Morgan 2026 with Liz Fowler, PhD, JD
Commercial health plans may have been missing from J.P. Morgan 2026, but government had a big presence! Value-Based Voices host Burt Zweigenhaft, PhD, and…
AVBCC Value-Based VoicesMore Insights from JP Morgan 2026 with Jeff Berkowitz, JD
Where was the drama at JP Morgan this year? Host Burt Zweigenhaft, PhD, and seasoned healthcare executive Jeff Berkowitz, JD, debate why the 2026 meeting…